Watch Demo

Canada Digestive System Disorder Industry Outlook 2022 - 2026

See how Canada Digestive System Disorder performed compared to key markets such as Germany, Japan and South Korea.

Key Market Indicators

Sales of digestive system disorder medication in Canada are set to reach $4.2 billion by 2026. In 2021, the market was worth $3.9 billion, and has grown an average of 1.2% every year since 2017. Canada was the fourth largest market for digestive system disorder medication in 2021, with South Korea overtaking to reach $3.9 billion. Japan, South Korea, and Canada were the number 2, 3, and 4 spots, respectively.

Marketing Banner

Canada Digestive System Disorder Market Data and Forecasts

How much will Canada Digestive System Disorder Market grow to 2026?

Forecast: Peptic Ulcer and Gastro-Oesophageal Reflux Diseases (GORD) Medicine Use in Canada
Forecast: Alimentary Tract and Metabolism Medicine Sales in Canada
Forecast: Alimentary Tract and Metabolism Medicine Sales in Canada
More in Digestive System Disorder Industry for 2028